Trade names from 'r-chin' to 'ramipril-nanolech®' - Electronic medicinal guide TALKDRUGS

A B AT D D E F З AND Y TO L M H ABOUT P R FROM T Have F X C H W E YU I
5 9 L
Capsules 150 mg, 300 mg, 450 mg, 600 mg.

Lyophilizate for the preparation of a solution for intravenous administration of 20 mg.


Tablets coated with enteric coating 10 mg and 20 mg.

Tablets are enteric, coated with 10 mg and 20 mg.

Capsules enteric, 10 mg and 20 mg.

Lyophilizate for the preparation of solution for subcutaneous and intramuscular injection.

Capsules intestine soluble 10 mg.


Lyophilizate for the preparation of solution for intramuscular injection 1 dose complete with a solvent.
Ointment for external use 0,1%.

Tablets of prolonged action, film-coated, 1.5 mg.

Concentrate for solution for infusion, 0.35%.
Raw vegetable-extract liquid.
Ointment for external use.

Tablets coated with enteric-coated shell, 10 mg and 20 mg.


Solution for subcutaneous administration, 100 units / ml.
Solution for subcutaneous administration, 100 units / ml.
Capsules.

Tablets, film-coated, 10 mg, 20 mg.

EvoFarm Ltd. Russia
Tablets 2.5 / 12.5 mg; 5/25 mg. For 7, 10 or 14 tablets in a blister of PVC / aluminum foil or in a blister of A1 / A1, laminated PVC;
Tablets of 1.25 mg, 2.5 mg, 5 mg and 10 mg. 30 tablets per bottle of polyethylene. 10 tablets per contour cell pack. Each
Tablets of 2.5 mg, 5 mg, 10 mg. 10 tablets per blister of A1 / A1. By 2, 3, 5, 10 blisters together with the instruction for use are placed
Capsules 2.5 mg, 5 mg, 10 mg. Primary packaging: 14 capsules in a blister of Al / PVC. Secondary packaging: 2 blisters together with instruction on
Tablets 2.5 mg, 5 mg and 10 mg. For 10 or 14 tablets in a contour mesh package.3 contour-cell packs of 10 tablets or 1,

Tablets, 2.5 mg, 5 mg and 10 mg.